losartan has been researched along with cytochrome c-t in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bo, L; Jin, F; Li, C; Li, P; Li, W; Liu, W; Lu, X; Mu, D; Pan, L; Sun, Y | 1 |
1 other study(ies) available for losartan and cytochrome c-t
| Article | Year |
|---|---|
Losartan, a selective antagonist of AT1 receptor, attenuates seawater inhalation induced lung injury via modulating JAK2/STATs and apoptosis in rat.
Topics: Acute Lung Injury; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Apoptosis; Cytochromes c; Janus Kinase 2; Losartan; Male; NF-kappa B; Phosphorylation; Rats; Rats, Sprague-Dawley; Seawater; STAT Transcription Factors | 2017 |